The fibrocyte in pulmonary hypertension: we seek him here, we seek him there

Toshner, Mark; Morrell, Nicholas W.

doi:10.1183/09031936.00127111

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It appears that these mesenchymal progenitor cells are capable of regulating fibrogenesis in the pulmonary arteries. Their numbers correlate with clinical and haemodynamic variables [9,10].…”

Section: Circulating Cellsmentioning

confidence: 98%

Pulmonary hypertension

Peacock¹

2013

Eur Respir Rev

View full text Add to dashboard Cite

2011 to 2012 has seen an explosion in published research in the field of pulmonary vascular disease, especially pulmonary hypertension. In conjunction with this research has been an explosion in clinical interest in treating pulmonary hypertension. This is possible because we now have three different generic classes of drug therapy: endothelin receptor antagonists, phosphodiesterase-5 inhibitors and prostacyclins. Clearly, however, we need to be careful that we are treating the correct disease with the correct drug and measuring the correct response. Herein, I will review the papers published over the last year that offer the most insight into the pathobiology, but also those that give us the clinical information we need in epidemiology, treatment and end-points so that we can treat this devastating group of disease.

show abstract

Section: Circulating Cellsmentioning

confidence: 98%

Pulmonary hypertension

Peacock¹

2013

Eur Respir Rev

View full text Add to dashboard Cite

show abstract

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases. Comprehensive Review of the Recent Literature 2010–2012

Weiss

2013

Annals ATS

View full text Add to dashboard Cite

A conference, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases," was held July 25 to 28, 2011, at the University of Vermont to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy and ex vivo bioengineering approaches for lung diseases. These are rapidly expanding areas of study that provide further insight into and challenge traditional views of mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, to discuss and debate current controversies, and to identify future research directions and opportunities for basic and translational research in cell-based therapies for lung diseases. The goal of this article, which accompanies the formal conference report, is to provide a comprehensive review of the published literature in lung regenerative medicine from the last conference report through December 2012.

show abstract

The fibrocyte in pulmonary hypertension: we seek him here, we seek him there

Cited by 2 publications

References 19 publications

Pulmonary hypertension

Pulmonary hypertension

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases. Comprehensive Review of the Recent Literature 2010–2012

Contact Info

Product

Resources

About